Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb;10(2):98-99.
doi: 10.1016/S2213-8587(21)00326-0. Epub 2021 Dec 15.

Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply

Mikhail N Kosiborod  1 , Russell Esterline  2 , Jan Oscarsson  3 , Samvel B Gasparyan  3 , Remo H M Furtado  4 , Subodh Verma  5 , Otavio Berwanger  6
Affiliations
Comment

Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply

Mikhail N Kosiborod et al. Lancet Diabetes Endocrinol. 2022 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

MNK has received a research grant for the conduct of this study from AstraZeneca. He has also received grant and research support from AstraZeneca. He has received a grant and honoraria from Boehringer-Ingelheim, and honoraria from Sanofi, Amgen, Novo Nordisk, Merck (Diabetes), Janssen, Bayer, Novartis, Eli Lilly, and Vifor Pharma outside the submitted work. RE, JO, and SBG are employees and stockholders of AstraZeneca. RHMF reports research grants and personal fees from AstraZeneca, Bayer, and Servier; and research grants from Pfizer, EMS, Aché, Brazilian Ministry of Health, University Health Network, and Lemann Foundation Research Fellowship. SV reports receiving grants, speaker honoraria and consulting fees from Boehringer‐Ingelheim, AstraZeneca, and Janssen. He has received speaker honoraria and consulting fees from Eli Lilly, and speaker honoraria from EOCI Pharmacomm, Sun Pharmaceuticals, and Toronto Knowledge Translation Working Group during the conduct of this study. He has also received grants and consulting fees from Amgen; grants, speaker honoraria and consulting fees from Bayer, and from Merck; grants from Bristol‐Myers Squibb; speaker honoraria and consulting fees from HLS Therapeutics, Novo Nordisk, and Sanofi; and speaker honoraria from Novartis. OB reports grants from AstraZeneca, Novartis, Bayer, Amgen, and Boehringer‐Ingelheim.

Comment on

References

    1. Kosiborod MN, Esterline R, Furtado RHM, et al. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021;9:586–594. - PMC - PubMed
    1. Chan L, Chaudhary K, Saha A, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32:151–160. - PMC - PubMed